Dr Arran Dokal

I have a background in cancer cell signalling and proteomics. My previous work focused on understanding the heterogeneity of kinase signalling networks in acute myeloid leukaemia, and how the microenvironment could influence these networks. In my current position I am investigating kinase dependencies in cholangiocarcinoma, with the aim of advancing personalised cancer therapies.